World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
20406
World Ranking
3194
National Ranking
272

Michael R. Ehrenstein publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael R. Ehrenstein sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 172 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael R. Ehrenstein D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Ehrenstein sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael R. Ehrenstein is affiliated with University College London in the United Kingdom. Their research predominantly spans the fields of Medicine and Immunology and Microbiology, with a notable focus on Rheumatology and Immunology as subfields of study. Specific areas of interest include Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, and Monoclonal and Polyclonal Antibodies Research.

The scientist's work encompasses various subjects related to autoimmune and inflammatory disorders, rheumatoid arthritis research and therapies, chronic lymphocytic leukemia research, and lymphoma diagnosis and treatment.

Michael R. Ehrenstein has been published in several academic venues, with frequent publications in the following journals:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Lancet Rheumatology
  • Scientific Reports
  • The Science of The Total Environment

Some of their recent papers include:

  • "Optimising fuel supply chains within planetary boundaries: A case study of hydrogen for road transport in the UK" (2020, Applied Energy)
  • "M3C: Monte Carlo reference-based consensus clustering" (2020, Scientific Reports)
  • "Unraveling the links between public spending and Sustainable Development Goals: Insights from data envelopment analysis" (2021, The Science of The Total Environment)
  • "Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab" (2022, Lara D. Veeken)
  • "Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials" (2023, The Lancet Rheumatology)

They have collaborated frequently with several co-authors, including:

  • Muhammad Shipa
  • Su-Ann Yeoh
  • Caroline Gordon
  • Edward M Vital
  • Peter Hewins

Best Publications

  • CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

    Paul A. Blair;Lina Yassin Noreña;Fabian Flores-Borja;David J. Rawlings

  • Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

    Michael R. Ehrenstein;Jamie G. Evans;Animesh Singh;Samantha Moore

  • An open study of B lymphocyte depletion in systemic lupus erythematosus

    Maria J. Leandro;Jonathan C. Edwards;Geraldine Cambridge;Michael R. Ehrenstein

  • CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.

    Fabian Flores-Borja;Anneleen Bosma;Dorothy Ng;Venkat Reddy

  • The importance of natural IgM: scavenger, protector and regulator

    Michael R. Ehrenstein;Clare A. Notley

  • Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis

    Jamie G. Evans;Karina A. Chavez-Rueda;Ayad Eddaoudi;Almut Meyer-Bahlburg

  • Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

    Maria J. Leandro;Geraldine Cambridge;Michael R. Ehrenstein;Jonathan C. W. Edwards

  • Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.

    Suchita Nadkarni;Claudia Mauri;Michael R. Ehrenstein

  • Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.

    Geraldine Cambridge;Maria J Leandro;Jonathan C W Edwards;Michael R Ehrenstein

  • Mice Lacking Endogenous IL-10–Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells

    Natalie A. Carter;Rita Vasconcellos;Elizabeth C. Rosser;Calogero Tulone

  • The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice

    Jeremy S. Brown;Tracy Hussell;Sarah M. Gilliland;David W. Holden

  • B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients

    M. J. Leandro;G. Cambridge;J. C. Edwards;M. R. Ehrenstein

  • Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting.

    Cristina Rada;Michael R. Ehrenstein;Michael S. Neuberger;César Milstein

  • Human FoxP3+ regulatory T cells in systemic autoimmune diseases

    Makoto Miyara;Guy Gorochov;Michael Ehrenstein;Lucile Musset

  • Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/ lpr Mice

    Paul A. Blair;Karina A. Chavez-Rueda;Jamie G. Evans;Mark J. Shlomchik

  • The ‘short’ history of regulatory B cells

    Claudia Mauri;Michael R. Ehrenstein

  • Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis

    Fabian Flores-Borja;Elizabeth C. Jury;Claudia Mauri;Michael R. Ehrenstein

  • Fifty years of anti-ds DNA antibodies: are we approaching journey's end?

    D. A. Isenberg;J. J. Manson;M. R. Ehrenstein;A. Rahman

  • Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response

    Michael R. Ehrenstein;Theresa L. O’Keefe;Sarah L. Davies;Michael S. Neuberger

  • International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

    D. A. Isenberg;E. Allen;V. Farewell;M. R. Ehrenstein

  • Cells of the synovium in rheumatoid arthritis

    Michael R Ehrenstein;Claudia Mauri

Frequent Co-Authors

David A. Isenberg
David A. Isenberg University College London
Claudia Mauri
Claudia Mauri University College London
Michael S. Neuberger
Michael S. Neuberger MRC Laboratory of Molecular Biology
Ian N. Bruce
Ian N. Bruce University of Manchester
Costantino Pitzalis
Costantino Pitzalis Queen Mary University of London
Deborah P. M. Symmons
Deborah P. M. Symmons University of Manchester
Michael R. Barnes
Michael R. Barnes Queen Mary University of London
Cesar Milstein
Cesar Milstein MRC Laboratory of Molecular Biology
Caroline Gordon
Caroline Gordon University of Birmingham
Marina Botto
Marina Botto Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can provide valuable career flexibility. Nursing programs, especially those with advanced practice options, offer a pathway to roles that intersect immunological knowledge and patient care. Prospective students may find some of the easiest NP programs to get into a good starting point, as these tend to have accessible admissions processes and can quickly lead to clinical roles.

Mental health nursing is another promising field closely connected to immunological research, particularly in understanding neuroimmune interactions. Those interested can consider top PMHNP programs for quality education coupled with strong clinical placement support, ensuring vital hands-on experience.

Cost is often a concern, so exploring cheapest PMHNP certificate programs can provide budget-friendly options without sacrificing essential training. Earning these credentials can boost employment opportunities in both psychiatric and immunology-related healthcare roles.

Finally, understanding the financial outlook is important. For advanced degrees, the doctorate in nursing salary information offers insight into potential earnings, helping students make informed decisions about pursuing higher education in nursing with a focus on immunology.

Best Scientists Citing Michael R. Ehrenstein

Trending Scientists

Recently Published Articles